Picture of Arix Bioscience logo

ARIX — Arix Bioscience Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+2.06%
3m-11.49%
6m-32.76%
1yr-36.5%
Volume Change (%)
10d/3m-24.69%
Price vs... (%)
52w High-42.29%
50d MA-4.44%
200d MA-23.12%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2.56%
Return on Equity14.61%
Operating Margin-1536.32%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for ARIX

Upbeat broker recommendations for Arix Bioscience background image

Upbeat broker recommendations for Arix Bioscience

The Arix Bioscience (LON:ARIX) share price has risen by 14.6% over the past month and it’s currently trading at 193.19. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...

Brokers bullish on Arix Bioscience shares background image

Brokers bullish on Arix Bioscience shares

The Arix Bioscience (LON:ARIX) share price has risen by 68.1% over the past month and it’s currently trading at 177. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont...

Analysts optimistic on Arix Bioscience outlook background image

Analysts optimistic on Arix Bioscience outlook

The Arix Bioscience (LON:ARIX) share price has risen by 46.5% over the past month and it’s currently trading at 162.25. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...

The Arix Bioscience share price – where next? background image

The Arix Bioscience share price – where next?

The Arix Bioscience (LON:ARIX) share price has risen by 12.5% over the past month and it’s currently trading at 109. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont...

The Arix Bioscience share price – where next? background image

The Arix Bioscience share price – where next?

The Arix Bioscience (LON:ARIX) share price has risen by 35.0% over the past month and it’s currently trading at 108.3901. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Arix Bioscience EPS forecast chart

Profile Summary

Arix Bioscience plc is a United Kingdom-based venture capital company that is focused on investing in and building biotechnology companies around advances in life sciences. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The Company's principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The Company's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
September 15th, 2015
Public Since
February 17th, 2017
No. of Employees
330
Sector
Investment Banking & Investment Services
Industry
Financials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
129,229,471

ARIX Share Price Performance

Similar to ARIX

Picture of 3i logo

3i

gb flag iconLondon Stock Exchange

Picture of Abrdn logo

Abrdn

gb flag iconLondon Stock Exchange

Picture of Adams logo

Adams

gb flag iconLondon Stock Exchange

Picture of Agronomics logo

Agronomics

gb flag iconLondon Stock Exchange

Picture of AJ Bell logo

AJ Bell

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email